Physician profile
Mark Ellis
NPI 1972897080
$5,562.73
in general payments reported to CMS, 2019-2025
19 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $2,629 · 2021: $903 · 2022: $1,453 · 2023: $73.46 · 2024: $70.03 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenex Health INC. | $2,528.58 | 2020 | |
| Impactortho, INC. | $1,220.91 | 2022 | |
| Orthofix Medical, INC. | $1,043.31 | 2019-2025 | Physio-Stim, Accelstim |
| Wright Medical Technology, INC. | $124.75 | 2019-2020 | |
| Organogenesis INC. | $124.73 | 2022-2025 | Simplimax |
| Janssen Scientific Affairs, LLC | $75.42 | 2019 | |
| Trice Medical, INC. | $73.60 | 2022 | |
| Nextremity Solutions INC. | $62.20 | 2019 | |
| Smith+Nephew, INC. | $53.54 | 2021-2023 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $46.41 | 2023-2024 | Nuzyra |
| Stryker Corporation | $36.47 | 2022 | |
| Mimedx Group, INC. | $29.22 | 2025 | |
| Bioventus LLC | $24.25 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $23.99 | 2019 | |
| Biowound Solutions, INC. | $20.05 | 2025 | Bio-Connekt |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $20.00 | 2019 | |
| Davol INC. | $19.74 | 2023 | Arista Ah Flexitip |
| Bayer Healthcare Pharmaceuticals INC. | $17.87 | 2022 | |
| Tactile Systems Technology INC | $17.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.